Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/157959
Kind Code:
A1
Abstract:
Disclosed are a pyrimidine compound, a preparation method therefor and the medical use thereof. In particular, the present invention relates to a pyrimidine compound represented by the general formula (I), and a preparation method therefor, and the use of same as an inhibitor of cyclin-dependent kinase 7 (CDK7), particularly the use in preventing and/or treating human diseases including cancers. Definitions of each group in the general formula (I) are as defined in the description.

Inventors:
SI JUTONG (CN)
JIANG MEIFENG (CN)
LI JIAYAN (CN)
ZHANG LIYUN (CN)
FAN PINGPING (CN)
Application Number:
PCT/CN2019/073874
Publication Date:
August 22, 2019
Filing Date:
January 30, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ANCUREALL PHARMACEUTICAL SHANGHAI CO LTD (CN)
International Classes:
C07D403/04; A61K31/506; A61P35/00
Domestic Patent References:
WO2014063068A12014-04-24
WO2015154039A22015-10-08
Other References:
KWIATKOWSKI, NICHOLAS: "Targeting transcription regulation in cancer with a covalent CDK7 inhibitor", NATURE, vol. 511, no. 7511, 31 July 2014 (2014-07-31), pages 616 - 620, XP055193048
WANG, YUBAO: "CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer", CELL ., vol. 163, no. 1, 24 September 2015 (2015-09-24), XP029280470, doi:10.1016/j.cell.2015.08.063
Attorney, Agent or Firm:
GE CHENG & CO. LTD. (CN)
Download PDF: